Health> Vol.5 No.8, August 2013

Impact of sexually transmitted infections on women health

DownloadDownload as PDF (Size:115KB) Full-Text HTML PP. 1216-1226   DOI: 10.4236/health.2013.58165

ABSTRACT

Sexually transmitted infections (STIs) are the infections that can be transmitted from one sex partner, who already has such infection, to another. The causes of STIs in human are very well elucidated and their causative agents are identified as bacteria, parasites and viruses. The worldwide epidemiology of more than 20 types of STIs has been established, which includes diseases like Chlamydia, Gonorrhea, Genital herpes, HIV/ AIDS, HPV, Syphilis and Trichomoniasis. Though STIs affect both men and women indiscriminately, however, the pathophysiology of disease is more obvious among women. Other than abstinence, the most effective way to prevent the transmission or acquisition of STIs is to use a condom during sexual intercourse. Condoms are effective in decreasing the transmission of HIV. However, once contacted, STIs caused by bacteria or parasites can be treated with antibiotics. STIs caused by a virus may not virtually have any cure though the medicines may keep the disease under control. Correct usage of preventive measures greatly reduces but does not completely eliminate the risk of catching or spreading STIs.

KEYWORDS


Cite this paper

Yadav, M. , Verma, N. and Dhanda, R. (2013) Impact of sexually transmitted infections on women health. Health, 5, 1216-1226. doi: 10.4236/health.2013.58165.

References

[1] Jindal, N., Arora, U., Singh, S. and Devi, B. (2012) Pre valence of sexually transmitted infections (HIV, Hepati tis B, Herpes simplex type 2 and Syphilis) among as ymptomatic pregnant women. The Journal of Obstetrics and Gynecology of India, 62, 158-161. doi:10.1007/s13224-012-0164-6
[2] Donders, G.G. (2000) Treatment of sexually transmitted bacterial diseases in pregnant women. Drugs, 59, 477-485. doi:10.2165/00003495-200059030-00005
[3] Hanson, J., Posner, S., Hassig, S., Rice, J. and Farley, T.A. (2005) Assessment of sexually transmitted diseases as risk factors for HIV seroconversion in a New Orleans sexually transmitted disease clinic, 1990-1998. Annals of Epidemiology, 15, 13-20. doi:10.1016/j.annepidem.2004.05.001
[4] Risbud, A. (2005) Human immunodeficiency virus (HIV) & sexually transmitted diseases (STDs). Indian Journal of Medical Research, 121, 369-376.
[5] Singhal, P., Naswa, S. and Marfatia, Y.S. (2009) Preg nancy and sexually transmitted viral infections. Indian Journal of Sexually Transmitted Diseases, 30, 71-78. doi:10.4103/0253-7184.62761
[6] Paavonen, J. and Eggert-Kruse, W. (1999) Chlamydia tra chomatis: Impact on human reproduction. Human Repro duction Update, 5, 433-447. doi:10.1093/humupd/5.5.433
[7] Chakravarti, A., Rawat, D. and Jain, M. (2005) A study on the perinatal transmission of the hepatitis B virus. In dian Journal of Medical Microbiology, 23, 128-130. doi:10.4103/02550857.16055
[8] Einwalter, L.A., Ritchie, J.M., Ault, K.A. and Smith, E.M. (2005) Gonorrhea and chlamydia infection among women visiting family planning clinics: Racial variation in preva lence and predictors. Perspectives on Sexual and Repro ductive Health, 37, 135-140. doi:10.1363/3713505
[9] Sayegh, M.A., Fortenberry, J.D., Anderson, J. and Orr, D.P. (2005) Relationship quality, coital frequency, and condom use as predictors of incident genital Chlamydia trachomatis infection among adolescent women. Journal of Adolescent Health, 37, 163. doi:10.1016/j.jadohealth.2004.08.018
[10] Bell, D.C., Mosier, V. and Atkinson, J.S. (2003) Protect ing oneself from human immunodeficiency virus: Are pre vention messages being heard? Clinical Infectious Dis eases, 37, S433-S438. doi:10.1086/377544
[11] Manhart, L.E. and Koutsky, L.A. (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A metaanalysis. Sexually Transmitted Diseases, 29, 725-735. doi:10.1097/0000743520021100000018
[12] Arora, P., Nagelkerke, N.J. and Jha, P. (2012) A system atic review and metaanalysis of risk factors for sexual transmission of HIV in India. PLoS One, 7, e44094. doi:10.1371/journal.pone.0044094
[13] Gerbase, A.C., Rowley, J.T. and Mertens, T.E. (1998) Global epidemiology of sexually transmitted diseases. Lancet, 351, 2-4. doi:10.1016/S01406736(98)900010
[14] Brunham, R.C., Paavonen, J., Stevens, C.E., Kiviat, N., Kuo, C.C., Critchlow, C.W. and Holmes, K.K. (1984) Mu copurulent cervicitis—The ignored counterpart in women of urethritis in men. The New England Journal of Medi cine, 311, 1-6. doi:10.1056/NEJM198407053110101
[15] Stamm, W.E., Wagner, K.F., Amsel, R., Alexander, E.R., Turck, M., Counts, G.W. and Holmes, K.K. (1980) Cau ses of the acute urethral syndrome in women. The New England Journal of Medicine, 303, 409-415. doi:10.1056/NEJM198008213030801
[16] Mardh, P.A., Ripa, T., Svensson, L. and Westrom, L. (1977) Chilamydia trachomatis infection in patients with acute salpingitis. The New England Journal of Medicine, 296, 1377-1379. doi:10.1056/NEJM197706162962403
[17] Hillis, S.D., Owens, L.M., Marchbanks, P.A., Amsterdam, L.F. and Mac Kenzie, W.R. (1997) Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. American Journal of Obstetrics & Gynecology, 176, 103-107. doi:10.1016/S0002-9378(97)80020-8
[18] Beem, M.O. and Saxon, E.M. (1977) Respiratorytract colonization and a distinctive pneumonia syndrome in in fants infected with Chlamydia trachomatis. The New Eng land Journal of Medicine, 296, 306-310. doi:10.1056/NEJM197702102960604
[19] Gravett, M.G., Nelson, H.P., DeRouen, T., Critchlow, C., Eschenbach, D.A. and Holmes, K.K. (1986) Independent associations of bacterial vaginosis and Chlamydia tracho matis infection with adverse pregnancy outcome. JAMA, 256, 1899-1903. doi:10.1001/jama.1986.03380140069024
[20] Gencay, M., Koskiniemi, M., Saikku, P., Puolakkainen, M., Raivio, K., Koskela, P. and Vaheri, A. (1995) Chla mydia trachomatis seropositivity during pregnancy is as sociated with perinatal complications. Clinical Infectious Diseases, 21, 424-426. doi:10.1093/clinids/21.2.424
[21] Geisler, W.M. (2011) Diagnosis and management of un complicated Chlamydia trachomatis infections in adoles cents and adults: summary of evidence reviewed for the 2010 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clinical Infec tious Diseases, 53, S92-S98. doi:10.1093/cid/cir698
[22] Smith, K.J., Hamza, S. and Skelton, H. (2004) Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clinical and Experimental Dermatology, 29, 505-512. doi:10.1111/j.1365-2230.2004.01593.x
[23] Bhatla, N., Puri, K., Joseph, E., Kriplani, A., Iyer, V.K. and Sreenivas, V. (2013) Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia: A pilot study. Indian Journal of Medical Research, 137, 533-539.
[24] Singh, V., Gupta, M.M., Satyanarayana, L., Parashari, A., Sehgal, A., Chattopadhya, D. and Sodhani, P. (1995) As sociation between reproductive tract infections and cer vical inflammatory epithelial changes. Sexually Transmit ted Infections, 22, 25-30. doi:10.1097/0000743519950100000005
[25] Surana, A., Rastogi, V., and Nirwan, P.S. (2012) Associa tion of the serum antichlamydial antibodies with tubal infertility. Journal of Clinical and Diagnostic Research, 6, 1692-1694.
[26] Knapp, J.S., Neal, S.W., Parekh, M.C. and Rice, R.J. (1995) In vitro activity of a new fluoroquinolone, CP99, 219, against strains of Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy, 39, 987-989. doi:10.1128/AAC.39.4.987
[27] Barry, P.M. and Klausner, J.D. (2009) The use of cepha losporins for gonorrhea: The impending problem of resis tance. Expert Opinion on Pharmacotherapy, 10, 555-577. doi:10.1517/14656560902731993
[28] Kent, M.E., Arora, A., Owen, P.J. and Khanduja, V. (2010) Assessment and correction of femoral malrotation fol lowing intramedullary nailing of the femur. Acta Orthopaedica Belgica, 76, 580-584.
[29] Stamm, L.V. (2010) Global challenge of antibioticresis tant Treponema pallidum. Antimicrobial Agents and Che motherapy, 54, 583-589. doi:10.1128/AAC.01095-09
[30] Weinstock, H., Berman, S. and Cates Jr., W. (2004) Sexu ally transmitted diseases among American youth: Inci dence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health, 36, 6-10. doi:10.1363/3600604
[31] Calonge, N. (2004) Screening for syphilis infection: Re commendation statement. Annals of Family Medicine, 2, 362-365. doi:10.1370/afm.215
[32] Schmid, G.P., Stoner, B.P., Hawkes, S. and Broutet, N. (2007) The need and plan for global elimination of congenital syphilis. Sexually Transmitted Diseases, 34, S5 10. doi:10.1097/01.olq.0000261456.09797.1b
[33] Lou, Y., Qesmi, R., Wang, Q., Steben, M., Wu, J. and Hef fernan, J.M. (2012) Epidemiological impact of a genital herpes type 2 vaccine for young females. PLoS One, 7, e46027. doi:10.1371/journal.pone.0046027
[34] Benedetti, J., Corey, L. and Ashley, R. (1994) Recurrence rates in genital herpes after symptomatic firstepisode in fection. Annals of Internal Medicine, 121, 847-854. doi:10.7326/0003-4819-121-11-199412010-00004
[35] Mertz, G.J., Schmidt, O., Jourden, J.L., Guinan, M.E., Re mington, M.L., Fahnlander, A., Winter, C., Holmes, K.K. and Corey, L. (1985) Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sexually Transmitted Diseases, 12, 33-39. doi:10.1097/00007435-198501000-00007
[36] Whitley, R.J., Kimberlin, D.W. and Roizman, B. (1998) Herpes simplex viruses. Clinical Infectious Diseases, 26, 541-553. doi:10.1086/514600
[37] Wald, A. and Link, K. (2002) Risk of human immunode ficiency virus infection in herpes simplex virus type 2-seropositive persons: A metaanalysis. The Journal of Infectious Diseases, 185, 45-52. doi:10.1086/338231
[38] Fleming, D.T., McQuillan, G.M., Johnson, R.E., Nahmias, A.J., Aral, S.O., Lee, F.K. and St Louis, M.E. (1997) Herpes simplex virus type 2 in the United States, 1976 to 1994. The New England Journal of Medicine, 337, 1105- 1111. doi:10.1056/NEJM199710163371601
[39] Xu, F., Sternberg, M.R., Kottiri, B.J., McQuillan, G.M., Lee, F.K., Nahmias, A.J., Berman, S.M. and Markowitz, L.E., (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA, 296, 964-973. doi:10.1001/jama.296.8.964
[40] Nahmias, A.J., Lee, F.K. and Beckman-Nahmias, S., (1990) Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scandinavian Journal of Infectious Diseases, 69, 19-36.
[41] Chayavichitsilp, P., Buckwalter, J.V., Krakowski, A.C. and Friedlander, S.F. (2009) Herpes simplex. Pediatrics in Review, 30, 119-129. doi:10.1542/pir.30-4-119
[42] Looker, K.J., Garnett, G.P. and Schmid, G.P. (2008) An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bulletin of the World Health Organization, 86, 805-812. doi:10.2471/BLT.07.046128
[43] Bharadwaj, M. Hussain, S. and Nasare, V. Das B.C. (2009) HPV & HPV vaccination: Issues in developing countries. Indian Journal of Medical Research, 130, 327- 333.
[44] Schiffman, M. and Kjaer, S.K. (2003) Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. JNCI Monographs, 31, 14-19.
[45] Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J. and Munoz, N. (1999) Human papillomavi rus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology, 189, 12-19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
[46] D’Souza, G., Kreimer, A.R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W.M., Westra, W.H. and Gillison, M.L. (2007) Casecontrol study of human papillomavirus and oropharyngeal cancer. The New England Journal of Me dicine, 356, 1944-1956. doi:10.1056/NEJMoa065497
[47] Ault, K.A. (2006) Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infectious Diseases in Obstetrics and Gynecology, 2006, 40470. doi:10.1155/IDOG/2006/40470
[48] Goldstein, M.A., Herzog, D.B., Misra, M. and Sagar, P. (2008) Case records of the Massachusetts General Hospi tal. Case 29-2008. A 19-year-old man with weight loss and abdominal pain. The New England Journal of Medi cine, 359, 1272-1283. doi:10.1056/NEJMcpc0804641
[49] Das, B.C. Bharti, A.C. and Bharadwaj, M. (2009) Human papillomavirus & cervical cancer: Looking ahead. Indian Journal of Medical Research, 130, 210-211.
[50] Kane, M.A. (1993) Progress on the control of hepatitis B infection through immunisation. Gut, 34, S10-S12. doi:10.1136/gut.34.2_Suppl.S10
[51] Tandon, B.N. (1995) HBV control in India. Indian Journal of Pediatrics, 62, 669-671. doi:10.1007/BF02825112
[52] Dhir, V.K. (1997) New approach to laboratory diagnosis. Africa Health, 20, 18.
[53] Kura, M.M., Hira, S., Kohli, M., Dalal, P.J., Ramnani, V.K. and Jagtap, M.R. (1998) High occurrence of HBV among STD clinic attenders in Bombay, India. Interna tional Journal of STD & AIDS, 9, 231-233. doi:10.1258/0956462981921954
[54] Risbud, A., Mehendale, S., Basu, S., Kulkarni, S., Walim be, A., Arankalle, V., Gangakhedkar, R., Divekar, A., Bollinger, R., Gadkari, D. and Paranjape, R. (2002) Pre valence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India. Sexually Transmitted Infections, 78, 169-173. doi:10.1136/sti.78.3.169
[55] Douek, D.C., Roederer, M. and Koup, R.A. (2009) Emer ging concepts in the immunopathogenesis of AIDS. Annual Review of Medicine, 60, 471-484. doi:10.1146/annurev.med.60.041807.123549
[56] Zetola, N.M. and Klausner, J.D. (2007) Syphilis and HIV infection: An update. Clinical Infectious Diseases, 44, 1222-1228. doi:10.1086/513427
[57] Gilbert, P.B., McKeague, I.W., Eisen, G., Mullins, C., Gueye-NDiaye, A., Mboup, S. and Kanki, P.J. (2003) Comparison of HIV-1 and HIV-2 infectivity from a pro spective cohort study in Senegal. Statistics in Medicine, 22, 573-593. doi:10.1002/sim.1342
[58] Reeves, J.D. and Doms, R.W. (2002) Human immunode ficiency virus type 2. Journal of General Virology, 83, 1253-1265.
[59] Lazzarin, A., Saracco, A., Musicco, M. and Nicolosi, A. (1991) Manto-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man’s infectiousness, and woman’s susceptibil ity. Italian Study Group on HIV Heterosexual Transmis sion. Archives of Internal Medicine, 151, 2411-2416. doi:10.1001/archinte.1991.00400120055009
[60] Thea, D.M., Steketee, R.W., Pliner, V., Bornschlegel, K., Brown, T., Orloff, S., Matheson, P.B., Abrams, E.J., Bamji, M., Lambert, G., Schoenbaum, E.A., Thomas, P.A., Heagarty, M. and Kalish, M.L. (1997) The effect of ma ternal viral load on the risk of perinatal transmission of HIV1. New York City Perinatal HIV Transmission Col laborative Study Group. AIDS, 11, 437-444. doi:10.1097/00002030-199704000-00006
[61] Mehendale, S.M., Shepherd, M.E., Divekar, A.D., Gangakhedkar, R.R., Kamble, S.S., Menon, P.A., Yadav, R., Risbud, A.R., Paranjape, R.S., Gadkari, D.A., Quinn, T.C., Bollinger, R.C. and Rodrigues, J.J. (1996) Evidence for high prevalence & rapid transmission of HIV among individuals attending STD clinics in Pune, India. Indian Journal of Medical Research, 104, 327-335.
[62] Walsh, T.J. and Dixon, D.M. (1996) Spectrum of Myco ses. In: Medical Microbiology, 4th Edition, University of Texas Medical Branch, Galveston.
[63] Kourkoumpetis, T., Manolakaki, D., Velmahos, G., Chang, Y., Alam, H.B., De Moya, M.M., Sailhamer, E.A. and Mylonakis, E. (2010) Candida infection and colonization among nontrauma emergency surgery patients. Virulence, 1, 359-366. doi:10.4161/viru.1.5.12795
[64] Lubelchek, R.J., Kroc, K.A., Levine, D.L., Beavis, K.G. and Roberts, R.R. (2011) Routine, rapid HIV testing of medicine service admissions in the emergency depart ment. Annals of Emergency Medicine, 58, S65-S70. doi:10.1016/j.annemergmed.2011.03.027
[65] Moodley, P., Wilkinson, D., Connolly, C., Moodley, J. and Sturm, A.W. (2002) Trichomonas vaginalis is associ ated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clinical Infectious Diseases, 34, 519-522. doi:10.1086/338399
[66] Sorvillo, F., Smith, L., Kerndt, P. and Ash, L. (2001) Tri chomonas vaginalis, HIV, and AfricanAmericans. Emer ging Infectious Diseases, 7, 927-932. doi:10.3201/eid0706.010603
[67] Viikki, M., Pukkala, E., Nieminen, P. and Hakama, M. (2000) Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncologica, 39, 71- 75. doi:10.1080/028418600431003
[68] Shafir, S.C., Sorvillo, F.J. and Smith, L. (2009) Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clinical Microbiology Reviews, 22, 37-45. doi:10.1128/CMR.00002-08
[69] Johnson, L.F., Coetzee, D.J. and Dorrington, R.E. (2005) Sentinel surveillance of sexually transmitted infections in South Africa: A review. Sexually Transmitted Infections, 81, 287-293. doi:10.1136/sti.2004.013904
[70] Yadav, M., Gupta, I. and Malla, N. (2005) Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: Prominence of IgG1 response. Parasite Immunology, 27, 461-467. doi:10.1111/j.1365-3024.2005.00800.x
[71] Soper, D. (2004) Trichomoniasis: Under control or undercontrolled? American Journal of Obstetrics & Gyne cology, 190, 281-290. doi:10.1016/j.ajog.2003.08.023
[72] Petrin, D., Delgaty, K., Bhatt, R. and Garber, G. (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clinical Microbiology Reviews, 11, 300-317.
[73] Yadav, M., Dubey, M.L., Gupta, I., Bhatti, G. and Malla, N. (2007) Cysteine proteinase 30 in clinical isolates of T. vaginalis from symptomatic and asymptomatic infected women. Experimental Parasitology, 116, 399-406. doi:10.1016/j.exppara.2007.02.007
[74] Sharma, A.K., Ranjan, R. and Mehta, G. (2004) Preva lence and determinants of reproductive tract infections among women. Journal of Communicable Diseases, 36, 93-99.
[75] Divekar, A.A., Gogate, A.S., Shivkar, L.K., Gogate, S. and Badhwar, V.R. (2000) Disease prevalence in women attending the STD clinic in Mumbai (formerly Bombay), India. International Journal of STD & AIDS, 11, 45-48. doi:10.1258/0956462001914896
[76] Das, A., Jana, S., Chakraborty, A.K., Khodakevich, L., Chakraborty, M.S. and Pal, N.K. (1994) Community based survey of STD/HIV infection among commercial sexworkers in Calcutta (India). PartIII: Clinical findings of sexually transmitted diseases (STD). Journal of Com municable Diseases, 26, 192-196.
[77] Patel, V., Weiss, H.A., Mabey, D., West, B., D’Souza, S., Patil, V., Nevrekar, P., Gupte, S. and Kirkwood, B.R. (2006) The burden and determinants of reproductive tract infections in India: A population based study of women in Goa, India. Sexually Transmitted Infections, 82, 243-249.
[78] Rathore, M., Vyas, L. and Bhardwaj, A.K. (2007) Preva- lence of reproductive tract infections amongst ever mar ried women and sociocultural factors associated with it. Journal of the Indian Medical Association, 105, 71-78.
[79] Conrad, M.D., Gorman, A.W., Schillinger, J.A., Fiori, P.L., Arroyo, R., Malla, N., Dubey, M.L., Gonzalez, J., Blank, S., Secor, W.E. and Carlton, J.M. (2012) Extensive genetic diversity, unique population structure and evi dence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis. PLoS Neglected Tropical Diseases, 6, e1573.
[80] Santelli, J.S., Robin, L., Brener, N.D. and Lowry, R. (2001) Timing of alcohol and other drug use and sexual risk behaviors among unmarried adolescents and young adults. Family Planning Perspectives, 33, 200-205. doi:10.2307/2673782
[81] Folch, C., Esteve, A., Sanclemente, C., Martro, E., Lugo, R., Molinos, S., Gonzalez, V., Ausina, V. and Casabona, J. (2008) Prevalence of human immunodeficiency virus, Chlamydia trachomatis, and Neisseria gonorrhoeae and risk factors for sexually transmitted infections among immigrant female sex workers in Catalonia, Spain. Sexu ally Transmitted Diseases, 35, 178-183. doi:10.1097/OLQ.0b013e31815a848d
[82] VallMayans, M., Villa, M., Saravanya, M., Loureiro, E., Merono, M., Arellano, E., Sanz, B., Saladie, P., Andreu, A. and Codina, M.G. (2007) Sexually transmitted Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV1 infec tions in two atrisk populations in Barcelona: Female street prostitutes and STI clinic attendees. International Journal of Infectious Diseases, 11, 115-122. doi:10.1016/j.ijid.2005.11.005
[83] Cates Jr. W. (1987) Tubal infertility: An ounce of (more specific) prevention. JAMA, 257, 2480. doi:10.1001/jama.1987.03390180098032
[84] Sellors, J.W., Mahony, J.B., Chernesky, M.A. and Rath, D.J. (1988) Tubal factor infertility: An association with prior chlamydial infection and asymptomatic salpingitis. Fertility and Sterility, 49, 451-457.
[85] Westrom, L. (1985) Influence of sexually transmitted di seases on sterility and ectopic pregnancy. Acta Euro paea Fertilitatis, 16, 21-24.
[86] Brown, Z.A., Vontver, L.A., Benedetti, J., Critchlow, C.W., Hickok, D.E., Sells, C.J., Berry, S. and Corey, L. (1985) Genital herpes in pregnancy: Risk factors associated with recurrences and asymptomatic viral shedding. American Journal of Obstetrics & Gynecology, 153, 24- 30.
[87] Brown, Z.A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R.L., Watts, D.H., Berry, S., Herd, M. and Corey, L. (1997) The acquisition of herpes simplex virus during pregnancy. The New England Journal of Medicine, 337, 509-515. doi:10.1056/NEJM199708213370801
[88] Fleming, D.T., McQuillan, G.M., Johnson, R.E., Nahmias, A.J., Aral, S.O., Lee, F.K. and St Louis, M.E. (1997) Her pes simplex virus type 2 in the United States, 1976 to 1994. The New England Journal of Medicine, 337, 1105- 1111. doi:10.1056/NEJM199710163371601
[89] Mertz, G.J., Schmidt, O., Jourden, J.L., Guinan, M.E., Remington, M.L., Fahnlander, A., Winter, C., Holmes, K.K. and Corey, L. (1985) Frequency of acquisition of firstepisode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sexually Transmitted Diseases, 12, 33-39.
[90] Wilkinson, D. (1999) Publicprivate health sector part nerships for STD control in developing countries: Per spectives from experience in rural South Africa. Sexually Transmitted Infections, 75, 285.
[91] Stamm, L.V. (2010) Global challenge of antibioticresis tant Treponema pallidum. Antimicrobial Agents and Chemotherapy, 54, 583-589. doi:10.1128/AAC.01095-09
[92] Snipes, L.J., Gamard, P.M., Narcisi, E.M., Beard, C.B., Lehmann, T. and Secor, W.E. (2000) Molecular epidemi ology of metronidazole resistance in a population of Tri chomonas vaginalis clinical isolates. Journal of Clinical Microbiology, 38, 3004-3009.
[93] Menezes, E.V., Yakoob, M.Y., Soomro, T., Haws, R.A., Darmstadt, G.L. and Bhutta, Z.A. (2009) Reducing still- births: Prevention and management of medical disorders and infections during pregnancy. BMC Pregnancy and Childbirth, 9, S4. doi:10.1186/1471-2393-9-S1-S4
[94] Barros, F.C., Bhutta, Z.A., Batra, M., Hansen, T.N., Vic tora, C.G. and Rubens, C.E. (2010) Global report on pre term birth and stillbirth (3 of 7): Evidence for effective ness of interventions. BMC Pregnancy and Childbirth, 10, S3. doi:10.1186/1471239310S1S3
[95] Blencowe, H., Cousens, S., Kamb, M., Berman, S. and Lawn, J.E. (2010) Lives saved tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health, 11, S9. doi:10.1186/1471245811S3S9
[96] Hawkes, S., Matin, N., Broutet, N. and Low, N. (2011) Effectiveness of interventions to improve screening for syphilis in pregnancy: A systematic review and meta analysis. The Lancet Infectious Diseases, 11, 684-691. doi:10.1016/S1473-3099(11)70104-9
[97] Cudmore, S.L. and Garber, G.E. (2010) Prevention or treatment: The benefits of Trichomonas vaginalis vaccine. Journal of Infection and Public Health, 3, 47-53. doi:10.1016/j.jiph.2010.01.003
[98] Van Der Pol, B., Williams, J.A., Orr, D.P., Batteiger, B.E. and Fortenberry, J.D. (2005) Prevalence, incidence, natu ral history, and response to treatment of Trichomonas va ginalis infection among adolescent women. The Journal of Infectious Diseases, 192, 2039-2044. doi:10.1086/498217
[99] Chen, K.T., Segu, M., Lumey, L.H., Kuhn, L., Carter, R.J., Bulterys, M. and Abrams, E.J. (2005) Genital herpes sim plex virus infection and perinatal transmission of human immunodeficiency virus. Obstetrics & Gynecology, 106, 1341-1348. doi:10.1097/01.AOG.0000185917.90004.7c
[100] Bell, D.C., Mosier, V. and Atkinson, J.S. (2003) Protect ing oneself from human immunodeficiency virus: Are prevention messages being heard? Clinical Infectious Diseases, 37, S433-S438. doi:10.1086/377544

comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.